Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Debra Armstrong"'
Autor:
Robert Jagodzinski, Katharin Pritchard, Jason Lau, Sandy Berzins, Robert Perry, Komal Jafri, Debra Armstrong, Lily Pang
Publikováno v:
International Journal of Population Data Science, Vol 3, Iss 4 (2018)
Introduction Compared to the public sector, not-for-profits are less focused on cross-agency data linkage. Technical capacity is often secondary to addressing caseloads and protecting clients. Clients’ privacy is paramount and can be perceived as a
Externí odkaz:
https://doaj.org/article/82af9d84662c47fcbb23d055caf06db4
Autor:
Jeremy Pettus, Erin R. Giovannetti, Leslie Carter, Daniel G. Ines, Debra Armstrong, Schafer Boeder, Paivi Burke
Publikováno v:
Diabetes. 69
Background: Diabetic ketoacidosis is a common and life-threatening complication of T1D. Glucagon stimulates ketogenesis via peripheral lipolysis and hepatic β-oxidation of free fatty acids (FFA). Blocking glucagon action may decrease ketone formatio
Autor:
Lily Pang, Debra Armstrong, Robert Perry, Katharin Pritchard, Sandy Berzins, Komal Jafri, Jason Lau, Robert Jagodzinski
Publikováno v:
International Journal of Population Data Science, Vol 3, Iss 4 (2018)
IntroductionCompared to the public sector, not-for-profits are less focused on cross-agency data linkage. Technical capacity is often secondary to addressing caseloads and protecting clients. Clients’ privacy is paramount and can be perceived as a
Publikováno v:
Lewis, P, Forster, A, Magowan, M & Armstrong, D 2018, ' Exploring the experiences and opinions of hospital pharmacists working 24/7 shifts ', European Journal of Hospital Pharmacy . https://doi.org/10.1136/ejhpharm-2017-001401
Eur J Hosp Pharm
Eur J Hosp Pharm
Objectives: The expansion of out of hours pharmacy services results from a drive to improve patient care and promote integration into the wider healthcare team. However, there has been little attempt to explore these intended outcomes as well as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fa616e86d138cbc6d868a4c3093f433
https://pure.manchester.ac.uk/ws/files/66923970/Exploring_the_experiences_and_opinions_of_hospital_pharmacists_working_247_shifts_in_a_hospital_AAM_2_.docx
https://pure.manchester.ac.uk/ws/files/66923970/Exploring_the_experiences_and_opinions_of_hospital_pharmacists_working_247_shifts_in_a_hospital_AAM_2_.docx
Autor:
Theodore P. Ciaraldi, Eric Chen Quin Lam, Debra Armstrong, Helle Linnebjerg, Melvin J. Prince, Scott J. Jacober, Parag Garhyan, Niels Porksen, Robert R. Henry, Paivi Burke, Jeremy Pettus, Vikram Sinha, Namrata Bose, S. L. Choi, Sunder Mudaliar, Mary Pat Knadler
Publikováno v:
Diabetes Care. 37:2609-2615
OBJECTIVE We evaluated the endogenous glucose production (EGP) and glucose disposal rate (GDR) over a range of doses of basal insulin peglispro (BIL) and insulin glargine in healthy subjects. RESEARCH DESIGN AND METHODS This was a single-center, rand
Autor:
Theodore P. Ciaraldi, Monica Ligueros-Saylan, Paivi Burke, Debra Armstrong, Robert R. Henry, Sunder Mudaliar
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 98:3446-3453
Pasireotide (SOM230) is a somatostatin analog with affinity for somatostatin receptor subtypes sst₁₋₃ and sst₅. Clinical trials have demonstrated the efficacy of pasireotide in treating Cushing's disease and acromegaly but have also shown adv
Autor:
Parag Garhyan, Niels Porksen, Paivi Burke, S. L. Choi, Mary Pat Knadler, Robert R. Henry, Helle Linnebjerg, Vikram Sinha, Debra Armstrong, Eric Chen Quin Lam, Theodore P. Ciaraldi, Scott J. Jacober, Jeremy Pettus, Sunder Mudaliar, N. Bose, Melvin J. Prince
Publikováno v:
Diabetes, obesitymetabolism. 18
Aims Basal insulin peglispro (BIL), a novel PEGylated basal insulin with a large hydrodynamic size, has a delayed absorption and reduced clearance that prolongs the duration of action. The current study compared the effects of BIL and insulin glargin
Autor:
Elizabeth K. Hussey, Annie A. Mavian, Robin L. O'Connor-Semmes, Debra Armstrong, Robert L. Dobbins, Sunder Mudaliar, June Ye, Robert R. Henry, Patricia K. Mydlow, Derek J. Nunez
Publikováno v:
Diabetes Care
OBJECTIVE Remogliflozin etabonate (RE), an inhibitor of the sodium-glucose transporter 2, improves glucose profiles in type 2 diabetes. This study assessed safety, tolerability, pharmacokinetics, and pharmacodynamics of RE in subjects with type 1 dia
Publikováno v:
Journal of Multi-Criteria Decision Analysis. 9:99-109
In a legal environment that prohibits discrimination in hiring, employee selection decisions should generally not be discriminatory in either the process or the final choice. Multi-criteria group decision support offers methodology to committees invo
Publikováno v:
Diabetes. 46:1586-1593
Impaired suppression of plasma nonesterified fatty acids (NEFAs) after glucose ingestion may contribute to glucose intolerance, but the mechanisms are unclear. Evidence that insulin inhibits hepatic glucose output (HGO), in part by suppressing plasma